Silent Signals in the Blood: Reframing Platelet Indices as Early Markers of Malaria Severity
Author(s): Mohammed Mustafa Hassan, Bashir Abdrhman Bashir
Background: Malaria is frequently associated with thrombocytopenia. The relationship between malaria and thrombocytopenia is thought to reflect platelet destruction or consumption during malaria infection. Platelets provide functions beyond blood coagulation, including combating infection and regulating inflammation.
Objective: To measure platelet indices and their correlation with parasite burden and clinical severity.
Methods: A comparative cross-sectional analysis was performed on 217 participants, including 167 malaria-positive and 50 malaria-negative participants. Platelet parameters, comprising platelet count (PLT), plateletcrit (PCT), platelet large cell count (PLCC), mean platelet volume (MPV), platelet distribution width (PDW), and platelet large cell ratio (PLCR), were examined. Nonparametric statistical approaches were used, and relationships with parasitemia were evaluated using Spearman’s rank correlation test.
Results: Malaria-positive individuals exhibited significantly reduced PLT (median 189 vs 302.5 ×109/L), PCT (0.156% vs 0.245%), PLCR (17.9% vs 22.2%), and PLCC (34.1 vs 66.8 ×109/L) (all p < 0.001) compared to controls. MPV was significantly lower in malaria cases (p < 0.001); however, it increased with rising parasitemia (ρ = 0.21, p = 0.008), suggesting a compensatory platelet response. PLT showed a strong inverse correlation with parasitemia (ρ = −0.53, p < 0.001). Additionally, Plasmodium vivax infection was associated with greater platelet depletion than P. falciparum infection.
Conclusion: Malaria is marked by pronounced thrombocytopenia and diminished platelet mass, with strong inverse correlations between platelet parameters and parasite load. Despite a general reduction in MPV in malaria cases, it is elevated with increased parasitemia, indicating a compensatory platelet response. Platelet indices, particularly PLT, PCT, and MPV, may serve as accessible biomarkers for assessing disease activity and severity.